Article PDF
Rights and permissions
About this article
Cite this article
Enzalutamid beim metastasierten hormon-sensitiven Prostatakarzinom (mHSPC). Urol. Prax. 21, 121 (2019). https://doi.org/10.1007/s41973-019-00070-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41973-019-00070-1